FDA Approved: LAZCLUZE — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved Lazertinib (LAZCLUZE) from Janssen Biotech, Inc. as the original application NDA for adult patients with non-small cell lung cancer whose disease p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LAZCLUZE (LAZERTINIB)

Snippet

ORIG AP for LAZCLUZE (LAZERTINIB)